Tarsus Pharmaceuticals, Inc. (TARS) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is held by 214 institutional firms.

• The collective stake of institutional investors in Tarsus Pharmaceuticals moved to 106.3% in September 2025, a shift down from the 108.6% reported for June 2025.
• The company experienced a -5.34% quarterly change in institutional shares held, alongside an increase of 32.92% in total owners annually.
• Of these 214 institutional investors, 91 increased their holdings in Tarsus Pharmaceuticals, while 99 of them reduced positions, and 24 investors maintained their exposure.
• The aggregate institutional position in Tarsus Pharmaceuticals now stands at 44.89Mn shares as of September 2025, after investors decreased their holdings (down by 2.53Mn shares quarter on quarter which is up 1.38Mn shares year over year).
• With 3.78Mn shares, BlackRock, Inc. commands the largest institutional position in Tarsus Pharmaceuticals as of September 30, 2025, equating to 8.95% of the company.
• Among the most significant buyers of Tarsus Pharmaceuticals during September 2025 were Deep Track Capital, LP (1.25Mn), LOOMIS SAYLES & CO L P (389.90K), Assenagon Asset Management S.A. (250.37K), Capricorn Fund Managers Ltd (240.02K), DRIEHAUS CAPITAL MANAGEMENT LLC (154.49K).
• Leading sellers of Tarsus Pharmaceuticals stock in September 2025 included CITADEL ADVISORS LLC (949.36K), TimesSquare Capital Management, LLC (925.15K), TORONTO DOMINION BANK (384.38K), JANUS HENDERSON GROUP PLC (367.95K), J. Goldman & Co LP (320.26K).
• The top 10 institutional holders of Tarsus Pharmaceuticals for the quarter ending September 2025 included BlackRock, Inc. (3.78Mn), RTW INVESTMENTS, LP (3.18Mn), Deep Track Capital, LP (3.00Mn), Paradigm Biocapital Advisors LP (2.67Mn), JENNISON ASSOCIATES LLC (2.60Mn), TANG CAPITAL MANAGEMENT LLC (2.45Mn), VANGUARD GROUP INC (2.27Mn), MORGAN STANLEY (1.91Mn), JANUS HENDERSON GROUP PLC (1.44Mn), Assenagon Asset Management S.A. (1.25Mn).